The usefulness of mild temperature hyperthermia combined with a newly developed hypoxia-oriented ¹⁰B conjugate compound, TX-2100, for boron neutron capture therapy

Shin-ichiro Masunaga Radiation Oncology Research Laboratory, Research Reactor Institute, Kyoto University, Osaka, JapanCorrespondence[email protected]

, MD, PhD,

Hideko Nagasawa Department of Biological Science and Technology, Faculty of Engineering, University of Tokushima, Tokushima, Japan

Yoshinori Sakurai Division of Radiation Life Science, Research Reactor Institute, Kyoto University, Kyoto University, Osaka, Japan

Yoshihiro Uto Department of Biological Science and Technology, Faculty of Engineering, University of Tokushima, Tokushima, Japan

Hitoshi Hori Department of Biological Science and Technology, Faculty of Engineering, University of Tokushima, Tokushima, Japan

Kenji Nagata Radiation Oncology Research Laboratory, Research Reactor Institute, Kyoto University, Osaka, Japan

Minoru Suzuki Radiation Oncology Research Laboratory, Research Reactor Institute, Kyoto University, Osaka, Japan

Akira Maruhashi Division of Radiation Life Science, Research Reactor Institute, Kyoto University, Kyoto University, Osaka, Japan

Yuko Kinashi Division of Radiation Safety, Research Reactor Institute, Kyoto University, Osaka, Japan

Koji Ono Radiation Oncology Research Laboratory, Research Reactor Institute, Kyoto University, Osaka, Japan

Your download is now in progress and you may close this window